A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma

Authors: Smaletz, Oren, Diz, Maria D.P.E., do Carmo, Claudio C., Sabbaga, Jorge, Cunha-Junior, Geraldo F., Azevedo, Sergio J., Maluf, Fernando C., Barrios, Carlos H., Costa, Ronaldo L., Fontana, Ana G., Madrigal, Vivian, Wainstein, Alberto J., Yeda, Fernanda P., Alves, Venâncio A., Moro, Ana M., Blasbalg, Roberto, Scott, Andrew M., Hoffman, Eric W.

Source: In Gynecologic Oncology August 2015 138(2):272-277